Search

Your search keyword '"Enomoto, Takayuki"' showing total 105 results
Start Over Author "Enomoto, Takayuki" Publisher american association for cancer research (aacr)
105 results on '"Enomoto, Takayuki"'

1. Supplementary Figure legend from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

2. Supplementary Table 3 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

3. Supplementary Table 7 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

4. Supplementary Table 7 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

5. Supplementary Table 8 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

6. Supplementary Table 6 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

7. Data from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

8. Supplementary Figure 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

9. Supplementary Figure 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

10. Supplementary Table 3 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

11. Supplementary Table 6 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

12. Supplementary Table 9 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

13. Supplementary Table 8 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

14. Supplementary Table 4 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

15. Supplementary Table 5 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

16. Supplementary Table 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

17. Supplementary Table 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

18. Data from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

19. Supplementary Table 4 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

20. Supplementary Table 5 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

21. Supplementary Figure 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

22. Supplementary Table 9 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

23. Supplementary Table 10 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

24. Supplementary Figure 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

25. Supplementary Table 10 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

26. Supplementary Table 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

27. Supplementary Table 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

28. Supplementary Figure legend from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

29. SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, additional, Ueda, Haruka, additional, Yamaguchi, Manako, additional, Yamawaki, Kaoru, additional, Tamura, Ryo, additional, Suda, Kazuaki, additional, Ishiguro, Tatsuya, additional, Adachi, Sosuke, additional, Nagase, Yoshikazu, additional, Ueda, Yutaka, additional, Ueda, Masashi, additional, Abiko, Kaoru, additional, Kagabu, Masahiro, additional, Baba, Tsukasa, additional, Nakaoka, Hirofumi, additional, Enomoto, Takayuki, additional, Murai, Junko, additional, and Yoshihara, Kosuke, additional

Published
2023
Full Text
View/download PDF

30. Supplementary Table S1 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

31. Data from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure S1 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure S1 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

34. Data from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 3 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure S2 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Table 5 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure S4 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Table 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Figure S3 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Table 6 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table S2 and S3 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Table S4 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Table 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 8 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Figure S4 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Table 6 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Table 1 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figure 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 7 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results